Search
01/09/2023
SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022) (vol 25, pg 2679, 2023)
Garcia-Campelo, R, Sullivan, I, Arriola, E, Insa, A, Vidal, OJ, Cruz-Castellanos, P, Moran, T, Reguart, N, Zugazagoitia, J, Domine, M. SEOM-GECP Clinical guidelines for diagnosis, treatment and follow-up of small-cell lung cancer (SCLC) (2022) (vol 25, pg 2679, 2023). Clinical & Translational Oncology. 2023; 25(9)DOI:10.1007/s12094-023-03290-7. PMID:37556098. IF:2.800(Q2/5D).
01/09/2023
mRNA-1273 SARS-CoV-2 vaccine in recently transplanted allogeneic hematopoietic cell transplant recipients: Dynamics of cellular and humoral immune responses and booster effect
Albiol, N, Lynton-Pons, E, Aso, O, Moga, E, Vidal, S, Gomez-Perez, L, Santiago, JA, Triquell, M, Roch, N, Lazaro, E, Gonzalez, I, Lopez-Contreras, J, Esquirol, A, Sierra, J, Martino, R, Garcia-Cadenas, I. mRNA-1273 SARS-CoV-2 vaccine in recently transplanted allogeneic hematopoietic cell transplant recipients: Dynamics of cellular and humoral immune responses and booster effect. LEUKEMIA RESEARCH. 2023; 132DOI:10.1016/j.leukres.2023.107347. PMID:37356281. IF:2.100(Q3/6D).
01/09/2023
Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non-Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA.
Gray JE, Ahn MJ, Oxnard GR, Shepherd FA, Imamura F, Cheng Y, Okamoto I, Cho BC, Lin MC, Wu YL, Majem M, Gautschi O, Boyer M, Bulusu KC, Markovets A, Barrett JC, Hodge R, McKeown A, Hartmaier RJ, Chmielecki J, Papadimitrakopoulou VA, Ramalingam SS. Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non-Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA.. CLINICAL CANCER RESEARCH. 2023; 29(17)DOI:10.1158/1078-0432.CCR-22-3146. PMID:37379430. IF:10.400(Q1/1D).
01/09/2023
Effectiveness and safety of tildrakizumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group
Berenguer-Ruiz S., Aparicio-Domínguez M., Herranz-Pinto P., Ruíz-Villaverde R., López-Ferrer A., Santos-Juanes J., Rodríguez Fernández-Freire L., Hospital-Gil M., Arias-Santiago S., Carretero-Hernández G., Mateu-Puchades A., Ferran M., del Alcázar E., Santos-Alarcón S., Garcia-Latasa de Aranibar F.J., Belinchón-Romero I., González-Cantero Á., Ruíz-Genao D., Eiris-Salvado N., Rocamora-Durán V., Rivera-Diaz R., de la Cueva P., Daudén E., Salgado-Boquete L., Llamas-Velasco M.. Effectiveness and safety of tildrakizumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; DOI:10.1111/jdv.19468. PMID:37625815. IF:8.500(Q1/1D).
01/09/2023
Role of ultrasound in acute respiratory failure and in the weaning of mechanical ventilation.
Zapata L, Blancas R, Conejo-Márquez I, García-de-Acilu M. Role of ultrasound in acute respiratory failure and in the weaning of mechanical ventilation.. Medicina Intensiva. 2023; 47(9)DOI:10.1016/j.medine.2023.03.018. PMID:37419839. IF:(Q/D).
01/09/2023
Correlation between C-reactive protein and the inflammatory ratios in acute schizophrenia inpatients: are they associated?
Llorca-Bofi, V, Bioque, M, Font, M, Gich, I, Mur, M. Correlation between C-reactive protein and the inflammatory ratios in acute schizophrenia inpatients: are they associated?. JOURNAL OF PSYCHIATRIC RESEARCH. 2023; 165DOI:10.1016/j.jpsychires.2023.07.023. PMID:37515951. IF:3.700(Q1/3D).